Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 1
1992 1
1993 5
1994 3
1995 1
1996 3
1997 1
1998 7
1999 6
2000 7
2001 6
2002 5
2003 11
2004 4
2005 14
2006 22
2007 14
2008 21
2009 29
2010 56
2011 58
2012 34
2013 51
2014 64
2015 68
2016 52
2017 83
2018 75
2019 97
2020 129
2021 168
2022 200
2023 225
2024 74

Text availability

Article attribute

Article type

Publication date

Search Results

1,430 results

Results by year

Filters applied: . Clear all
Page 1
Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target.
Wang K, Zhang Z, Hang J, Liu J, Guo F, Ding Y, Li M, Nie Q, Lin J, Zhuo Y, Sun L, Luo X, Zhong Q, Ye C, Yun C, Zhang Y, Wang J, Bao R, Pang Y, Wang G, Gonzalez FJ, Lei X, Qiao J, Jiang C. Wang K, et al. Among authors: zhuo y. Science. 2023 Aug 4;381(6657):eadd5787. doi: 10.1126/science.add5787. Epub 2023 Aug 4. Science. 2023. PMID: 37535747
Interferon and interferon-stimulated genes in HBV treatment.
Li Q, Sun B, Zhuo Y, Jiang Z, Li R, Lin C, Jin Y, Gao Y, Wang D. Li Q, et al. Among authors: zhuo y. Front Immunol. 2022 Dec 1;13:1034968. doi: 10.3389/fimmu.2022.1034968. eCollection 2022. Front Immunol. 2022. PMID: 36531993 Free PMC article. Review.
A tool kit of highly selective and sensitive genetically encoded neuropeptide sensors.
Wang H, Qian T, Zhao Y, Zhuo Y, Wu C, Osakada T, Chen P, Chen Z, Ren H, Yan Y, Geng L, Fu S, Mei L, Li G, Wu L, Jiang Y, Qian W, Zhang L, Peng W, Xu M, Hu J, Jiang M, Chen L, Tang C, Zhu Y, Lin D, Zhou JN, Li Y. Wang H, et al. Among authors: zhuo y. Science. 2023 Nov 17;382(6672):eabq8173. doi: 10.1126/science.abq8173. Epub 2023 Nov 17. Science. 2023. PMID: 37972184
Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1-Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial.
Xu Q, Wang J, Sun Y, Lin Y, Liu J, Zhuo Y, Huang Z, Huang S, Chen Y, Chen L, Ke M, Li L, Li Z, Pan J, Song Y, Liu R, Chen C. Xu Q, et al. Among authors: zhuo y. J Clin Oncol. 2022 Jun 1;40(16):1795-1805. doi: 10.1200/JCO.21.02091. Epub 2022 Feb 22. J Clin Oncol. 2022. PMID: 35192397 Free PMC article. Clinical Trial.
Research advances in drug therapy of endometriosis.
Shi J, Tan X, Feng G, Zhuo Y, Jiang Z, Banda S, Wang L, Zheng W, Chen L, Yu D, Guo C. Shi J, et al. Among authors: zhuo y. Front Pharmacol. 2023 Jun 21;14:1199010. doi: 10.3389/fphar.2023.1199010. eCollection 2023. Front Pharmacol. 2023. PMID: 37416064 Free PMC article. Review.
1,430 results